“Buy These 3 Dividend Stocks for Lifelong Passive Income!” | (जीवन भर निष्क्रिय आय के लिए 3 लाभांश वृद्धि स्टॉक अभी खरीदें )

Main Points In Hindi (मुख्य बातें – हिंदी में)

यहां कुछ मुख्य बिंदु हैं जो आपके द्वारा साझा की गई सामग्री के बुनियादी विचारों को संक्षेपित करते हैं:

1. लाभांश आय के दो तरीके: यह लेख व्यक्तिगत निवेशकों को दो अलग-अलग तरीकों से लाभांश आय स्ट्रीम स्थापित करने की सलाह देता है: अत्यधिक उच्च पैदावार वाले शेयरों में निवेश करना और उन कंपनियों में निवेश करना जो लाभांश बढ़ाने की प्रवृत्ति रखती हैं।

2. आर्चर-डेनियल-मिडलैंड (ADM): यह कंपनी एक प्रमुख कृषि आपूर्ति श्रृंखला प्रबंधक है, जो वर्तमान में 3.4% लाभांश उपज प्रदान करती है और 2020 के बाद से इसके लाभांश में हर वर्ष 8.6% की वृद्धि हुई है। ADM की स्थिरता इसके मजबूत वैश्विक नेटवर्क और अर्थव्यवस्थाओं के पैमाने में निहित है।

3. हरक्यूलिस कैपिटल: यह कंपनी जीवन विज्ञान के स्टार्ट-अप के लिए विशेष वित्तीय समाधान प्रदान करती है और 2009 से अपने लाभांश भुगतान को स्थिर या बढ़ा रही है। वर्तमान में यह 9.5% लाभांश उपज प्रदान करती है, यदि इसके दोनों लाभांश स्थिर रहते हैं।

4. रॉयल्टी फार्मा: यह कंपनी दवा निर्माताओं से भविष्य की बिक्री का प्रतिशत मांगती है। वर्तमान में, यह 3% लाभांश उपज प्रदान कर रही है और 2020 के बाद से इसके लाभांश भुगतान में 40% की वृद्धि हुई है।

5. लंबी अवधि के निवेश का महत्व: लेख में कहा गया है कि निवेशकों को इन कंपनियों को एक दशक तक अपने पोर्टफोलियो में बनाए रखने का विचार करना चाहिए ताकि वे भविष्य में बेहतर लाभांश आय का आनंद उठा सकें।

Main Points In English(मुख्य बातें – अंग्रेज़ी में)

Here are the main points from the text regarding dividend income investment strategies:

- Advertisement -

1. Two Approaches to Dividend Income: Investors can choose between high-yield dividend stocks for immediate income or companies that show consistent dividend growth over time, which may take longer but can lead to significantly higher income upon retirement.

2. Archer-Daniels-Midland (ADM): ADM is a leading agricultural supply chain manager with a current 3.4% dividend yield, and it has increased its dividend by 8.6% annually since 2020. Despite fluctuating commodity prices, ADM has maintained strong cash flow, allowing for continued dividend growth.

3. Hercules Capital: This business development company focuses on financing startups in the life sciences sector. It has increased its quarterly dividend by 50% since 2020 and offers a yield of up to 9.5%, emphasizing the potential for ongoing dividend growth.

4. Royalty Pharma: Royalty Pharma specializes in providing capital to drug manufacturers in exchange for a percentage of their future sales. With a dividend yield of 3% and a 40% increase in dividends since 2020, the company has a promising outlook for future payments, especially with substantial investments made recently.

5. Investment Strategy: Investors are encouraged to identify and hold onto quality stocks like ADM, Hercules Capital, and Royalty Pharma for the long term to build a sustainable and growing stream of passive income, potentially enhancing their financial security in retirement.

Complete News In Hindi(पूरी खबर – हिंदी में)

Complete News In English(पूरी खबर – अंग्रेज़ी में)

If you’re an individual investor trying to establish a stream of dividend income to support your retirement dreams, there are two distinct approaches to achieve this. One option is to fill your portfolio with stocks that offer high yields, but it’s important to note that high dividend yields usually come from companies that are not expected to grow significantly in the market.

- Advertisement -

The second approach takes more time but can be much more effective in the long run. Companies like Archer-Daniels-Midland (NYSE: ADM), Hercules Capital (NYSE: HTGC), and Royalty Pharma (NASDAQ: RPRX) are rapidly increasing their dividend payments. While their current yields may not be very exciting, investors who hold onto these stocks for longer can end up with a substantial stream of passive income when they retire.

Let’s explore why investors might want to add these stocks to their portfolios and hold them for at least a decade.

1. Archer-Daniels-Midland

Archer-Daniels-Midland (ADM) is a leading agricultural supply chain manager and processor. The stock currently offers a 3.4% dividend yield and has increased its payouts by 8.6% annually since 2020.

If you’ve eaten canned food recently, it’s likely that ADM was involved in sourcing, transporting, or processing some ingredients. With resources in over 190 countries, ADM is well-positioned in the agricultural sector.

While many businesses can process soybeans, competing with ADM’s established operations is challenging, making them a preferred supplier for food producers. ADM’s economies of scale allow it to generate consistent profits, even during downturns in commodity prices. Despite a 30% year-over-year decline in operational profits in early 2024, the company still generated $3.16 billion in free cash flow, requiring only 31% of that to meet its dividend obligations, indicating room for future increases.

2. Hercules Capital

Hercules Capital specializes in financing start-ups in the life sciences and technology sectors. Investing in early-stage companies carries significant risk, but winning investments can lead to substantial payoffs.

The company’s regular quarterly dividends have been stable or increasing since 2009, thanks to equity stakes in successful firms like Palantir Technologies and Exosome Therapeutics. As a Business Development Company (BDC), Hercules is able to distribute at least 90% of its profits as dividends, minimizing tax liabilities. Recent buyers could see yields of 9.5% if dividends remain stable through 2025. Even if its supplemental dividends were cut to zero, investors would still receive a 7.9% yield from regular payments.

Since 2020, Hercules has raised its quarterly payouts by 50%, and with $462 million invested in just the second quarter—up 27% from the previous year—there’s potential for continued dividend growth.

3. Royalty Pharma

Royalty Pharma focuses solely on helping pharmaceutical companies fund their clinical trials but instead of demanding monthly loan repayments, it requests a percentage of their future drug sales. At current prices, it offers a 3% dividend yield.

Start-up biotech firms often face costs of up to $1 billion before they have a product to sell. Royalty Pharma has a proven track record of selecting promising drugs, with over 35 commercially available products currently in its portfolio.

Since 2020, Royalty Pharma has invested about $15 billion and is ramping up activity, investing nearly $2 billion in just the second quarter. The company has raised its dividends by 40% since 2020, and substantial future increases are expected, aiming for a 9% to 12% increase in royalty revenues this year. For investors who buy now and hold long-term, substantial future dividend payments could be on the horizon.

Seize the Opportunity

If you’ve ever felt like you missed out on investing in the best stocks, you’ll want to hear this. Our expert analysts highlight rare opportunities with their "Double Down" stock recommendations—companies they believe are on the rise. If you’re worried you’ve missed your chance to invest, now might be the best time to do so.

Some notable past investments include:

• Amazon: A $1,000 investment in 2010 would now be worth $21,285.
• Apple: A $1,000 investment in 2008 would have grown to $44,456.
• Netflix: A $1,000 investment in 2004 would now be $411,959.

We’re issuing "Double Down" alerts for three incredible companies, underscoring a unique investing opportunity.

Read about these stocks now

For more insights on these "Double Down" stocks, visit the link provided.

Remember, successful investing often requires holding onto stocks long-term to reap the rewards!

Source link